Rapid Reversal of the Diabetic Endothelial Dysfunction by Pharmacological Inhibition of Poly(ADP-Ribose) Polymerase

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Circulation Research

• Publication date

  2001-10-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/HH2001.097797PMID 11597991
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored byUNESCO‐MCBN, the American Diabetes Association and the German Diabetes Society

  2001cited by this paper
• Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation

  2001cited by this paper
• Inhibition of poly (ADP‐ribose) synthetase by gene disruption or inhibition with 5‐iodo‐6‐amino‐1,2‐benzopyrone protects mice from multiple‐low‐dose‐streptozotocin‐induced diabetes

  2001cited by this paper
• Time course of changes in endothelium-dependent and -independent relaxation of chronically diabetic aorta: role of reactive oxygen species.

  2000cited by this paper
• Protective effect of poly(ADP-ribose) polymerase inhibitors against cell damage induced by antiviral and anticancer drugs

  2000cited by this paper
• GPI 6150 prevents H(2)O(2) cytotoxicity by inhibiting poly(ADP-ribose) polymerase.

  2000cited by this paper
• Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes.

  2000cited by this paper
• Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase.

  2000cited by this paper
• Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors.

  2000cited by this paper
• Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

  2000cited by this paper
• Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension.

  2000cited by this paper
• Cancer cell selectivity of 5-iodo-6-aminobenzopyrone (INH2BP) and methyl-3,5-diiodo-4(4'-methoxyphenoxy) benzoate (DIME).

  2000cited by this paper
• Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes.

  1999cited by this paper
• Vascular function in Type 2 diabetes mellitus and pre‐diabetes: the case for intrinsic endotheliopathy

  1999cited by this paper
• Reducing the burden of diabetes: managing cardiovascular disease †

  1999cited by this paper
• Generation of reactive oxygen intermediates, activation of NF-kappaB, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase?

  1999cited by this paper
• Ultrastructural changes and immunohistochemical localization of nitric oxide synthase, advanced glycation end products and NF-kappa B in aorta of streptozotocin treated Mongolian gerbils.

  1999cited by this paper
• Resistance to endotoxic shock as a consequence of defective NF‐κB activation in poly (ADP‐ribose) polymerase‐1 deficient mice

  1999cited by this paper
• Increased superoxide anion formation in endothelial cells during hyperglycemia: an adaptive response or initial step of vascular dysfunction?

  1999cited by this paper
• Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes.

  1999cited by this paper
• Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin

  1999cited by this paper
• A multi‐centre randomized trial of two different doses of nicotinamide in patients with recent‐onset Type 1 diabetes (the IMDIAB VI)

  1999cited by this paper
• Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors.

  1998cited by this paper
• Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion.

  1998cited by this paper
• Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury.

  1998cited by this paper
• Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation.

  1998cited by this paper
• Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase.

  1998cited by this paper
• Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C.

  1997cited by this paper
• Cytosolic NADH/NAD+ , free radicals, and vascular dysfunction in early diabetes mellitus

  1997cited by this paper
• Role of oxidative metabolism on endothelium-dependent vascular relaxation of isolated vessels.

  1997cited by this paper
• High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells.

  1997cited by this paper
• Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite.

  1997cited by this paper
• DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite.

  1996cited by this paper
• High-performance liquid chromatography analysis of oxidized and reduced pyridine dinucleotides in specific brain regions.

  1995cited by this paper
• Increased adhesion of neutrophils to retinal vascular endothelial cells exposed to hyperosmolarity.

  1994cited by this paper
• Interference of Glycosylated Human Hemoglobin With Endothelium‐Dependent Responses

  1993cited by this paper
• Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase.

  1992cited by this paper
• Effects of metabolic inhibitors on endothelium‐dependent and endothelium‐independent vasodilatation of rat and rabbit aorta

  1991cited by this paper
• Protection by 3-aminobenzamide and nicotinamide against streptozotocin-induced beta-cell toxicity in vivo and in vitro.

  1990cited by this paper
• Loss of the MYC gene amplified in human HL-60 cells after treatment with inhibitors of poly(ADP-ribose) polymerase or with dimethyl sulfoxide.

  1989cited by this paper
• Oxygen Free-Radical Scavengers and Immune Destruction of Murine Islets in Allograft Rejection and Multiple Low-Dose Streptozocin-Induced Insulitis

  1989cited by this paper
• Poly(ADP-ribose) in the cellular response to DNA damage.

  1985cited by this paper
• Effect of Poly(ADP-ribose) Synthetase Inhibitor Administration to Rats Before and After Injection of Alloxan and Streptozotocin on Islet Proinsulin Synthesis

  1983cited by this paper
• Synthesis and Biological Properties of Benzimidazole Inhibitors of the DNA Repair Enzyme Poly ( ADP-ribose ) Polymerase

  year unknowncited by this paper

• Nicotinamide N-methyltransferase in cardiovascular Diseases: Mechanistic insights and therapeutic potential.

  2025cites this paper
• siRNA targeting PARP-1 alleviates diabetic peripheral neuropathy in a streptozotocin-induced rat model

  2024cites this paper
• NAMPT/NAD+/PARP1 Pathway Regulates CFA‐Induced Inflammatory Pain via NF‐κB Signaling in Rodents

  2024cites this paper
• Camel whey protein improves diabetic liver injury by targeting ACMSD and promoting de novo NAD+ synthesis

  2023cites this paper
• Interplay between fish oil, obesity and cardiometabolic diabetes.

  2023cites this paper
• Viewing teratogens through the lens of nicotinamide adenine dinucleotide (NAD+)

  2022cites this paper
• Molecular Insights on the Therapeutic Effect of Selected Flavonoids on Diabetic Neuropathy.

  2022cites this paper
• Suppression of oxidative-stress induced melanocyte death: Role of poly(ADP-ribose) polymerase in vitiligo pathogenesis.

  2022cites this paper
• FBXW7 alleviates hyperglycemia-induced endothelial oxidative stress injury via ROS and PARP inhibition

  2022cites this paper
• Poly (ADP‐ribose) polymerase 1‐mediated defective mitophagy contributes to painful diabetic neuropathy in the db/db model

  2022cites this paper
• Targeting DNA damage response in cardiovascular diseases: from pathophysiology to therapeutic implications.

  2022cites this paper
• NAD+ metabolism in peripheral neuropathic pain.

  2022cites this paper
• Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease Mycobacterium tuberculosis Survival in Human Macrophages

  2021cites this paper
• Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Reduces Brain Damage after Stroke in the Neonatal Mouse Brain

  2021cites this paper
• Impaired nicotinamide adenine dinucleotide (NAD+) metabolism in diabetes and diabetic tissues: Implications for nicotinamide‐related compound treatment

  2020cites this paper
• Role of PARP-1 in mitochondrial homeostasis.

  2020cites this paper
• Cerebral Vasodilator Property of Poly(ADP-Ribose) Polymerase Inhibitor (PJ34) in the Neonatal and Adult Mouse Is Mediated by the Nitric Oxide Pathway

  2020cites this paper
• The role of ADP-ribose metabolism in metabolic regulation, adipose tissue differentiation, and metabolism

  2020cites this paper
• Doxorubicin-induced testicular damage is related to PARP-1 signaling molecules in mice

  2019cites this paper
• Oxidative Stress Mechanisms in Type 2 Diabetes Induced Coronary Heart Disease

  2019cites this paper
• Role of endothelial NAD+ deficiency in age-related vascular dysfunction.

  2019cites this paper
• Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus?

  2019cites this paper
• Treatment with the poly(ADP-ribose) polymerase inhibitor PJ-34 improves cerebromicrovascular endothelial function, neurovascular coupling responses and cognitive performance in aged mice, supporting the NAD+ depletion hypothesis of neurovascular aging

  2019cites this paper
• PARP-1 (Poly[ADP-Ribose] Polymerase 1) Inhibition Protects From Ang II (Angiotensin II)–Induced Abdominal Aortic Aneurysm in Mice

  2018cites this paper
• Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy

  2018cites this paper
• Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders

  2018cites this paper
• Poly‐ADP‐ribose polymerase inhibition enhances ischemic and diabetic wound healing by promoting angiogenesis

  2017cites this paper
• Ginger Ingredients Alleviate Diabetic Prostatic Complications: Effect on Oxidative Stress and Fibrosis

  2017cites this paper
• Protocatechuic Acid, a Phenolic from Sansevieria roxburghiana Leaves, Suppresses Diabetic Cardiomyopathy via Stimulating Glucose Metabolism, Ameliorating Oxidative Stress, and Inhibiting Inflammation

  2017cites this paper
• Effect of the Anti-retroviral Drugs Efavirenz, Tenofovir and Emtricitabine on Endothelial Cell Function: Role of PARP

  2017cites this paper
• Targeting endothelial metaflammation to counteract diabesity cardiovascular risk: Current and perspective therapeutic options

  2017cites this paper
• Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies.

  2016cites this paper
• EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

  2016cites this paper
• Cardiovascular Protective Effect of Metformin and Telmisartan: Reduction of PARP1 Activity via the AMPK-PARP1 Cascade

  2016cites this paper
• EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication☆☆☆

  2016cites this paper
• EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication.

  2016cites this paper
• cardiopulmonary bypass with cardiac arrest mesenteric vascular injury induced by experimental Poly(ADP-ribose) polymerase inhibitor PJ-34 reduces

  2016cites this paper
• Depletion of NAD pool contributes to impairment of endothelial progenitor cell mobilization in diabetes.

  2016cites this paper
• EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: De fi nition, characterisation, and clinical implication $ , $$ Journal of Arrhythmia

  2016cites this paper
• PARP-1 inhibition alleviates diabetic cardiac complications in experimental animals.

  2016cites this paper
• Diabetic Cardiomyopathy: Intersection of Macrovascular and Microvascular Disease, or Much More?

  2016cites this paper
• Diyabetik Kardiyomiyopati ve Moleküler Temeli: Derleme

  2015cites this paper
• Nuclear factor kappa B inhibition improves conductance artery function in type 2 diabetic mice

  2015cites this paper
• Vasoactivity of Rucaparib, a PARP-1 Inhibitor, is a Complex Process that Involves Myosin Light Chain Kinase, P2 Receptors, and PARP Itself

  2015cites this paper
• Evaluation of Neuroprotective Interventions in Different Pde 6 a Mutant Animal Models for Retinitis Pigmentosa

  2015cites this paper
• Investigation of anti-diabetic properties of Psidium guajava leaf in streptozocin induced diabetic rats.

  2015cites this paper
• Identification and mechanism of action analysis of the new PARP-1 inhibitor 2″-hydroxygenkwanol A.

  2015cites this paper
• Low Shear Stress Induced HMGB1 Translocation and Release via PECAM-1/PARP-1 Pathway to Induce Inflammation Response

  2015cites this paper
• Effect of Nobiletin on Diabetic Neuropathy in Experimental Rats

  2015cites this paper
• Pathogenesis of diabetic cerebral vascular disease complication.

  2015cites this paper
• Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy.

  2015cites this paper
• Oxidative Stress and Cardiovascular Disease in Diabetes

  2014cites this paper
• Resveratrol and Cerebral Arterioles during Type 1 Diabetes

  2014cites this paper
• Poly(ADP‐ribose) Polymerase 1 (PARP1) in Atherosclerosis: From Molecular Mechanisms to Therapeutic Implications

  2014cites this paper
• Tonicity-responsive enhancer binding protein regulates the expression of aldose reductase and protein kinase C δ in a mouse model of diabetic retinopathy.

  2014cites this paper
• The Poly(Adenosine Diphosphate-Ribose) Polymerase Inhibitor PJ34 Reduces Pulmonary Ischemia-Reperfusion Injury in Rats

  2014cites this paper
• Polymorphisms in oxidative stress pathway genes and risk of diabetic nephropathy in South Indian type 2 diabetic patients

  2014cites this paper
• Cerebrovascular Disease in Type 1 Diabetes: Role of Oxidative Stress

  2014cites this paper
• Cardiovascular side effects of the antiretroviral agents rilpivirine, efavirenz, etravirine and abacavir: possible underlying mechanisms

  2014cites this paper
• IMPACT OF OXIDATIVE STRESS IN DEVELOPMENT OF DIABETIC RETINOPATHY AND ANTIOXIDANTS AS TREATMENT OPTION

  2014cites this paper
• Hesperidin, a flavanoglycone attenuates experimental diabetic neuropathy via modulation of cellular and biochemical marker to improve nerve functions

  2014cites this paper
• Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

  2013cites this paper
• Reduced Estradiol-Induced Vasodilation and Poly-(ADP-Ribose) Polymerase (PARP) Activity in the Aortas of Rats with Experimental Polycystic Ovary Syndrome (PCOS)

  2013cites this paper
• Effects of Crataegus microphylla on Vascular Dysfunction in Streptozotocin‐induced Diabetic Rats

  2013cites this paper
• Molecular biology of atherosclerosis.

  2013cites this paper
• Resveratrol protects against vinorelbine-induced vascular endothelial cell injury

  2013cites this paper
• Determinants of myocardial and vascular function in young subjects with Type 1 diabetes mellitus

  2012cites this paper
• Contribution of PARP to endothelial dysfunction and hypertension in a rat model of pre‐eclampsia

  2012influential citation
• Poly(ADP-ribose) polymerase inhibition improves erectile function by activation of nitric oxide/cyclic guanosine monophosphate pathway in diabetic rats.

  2012cites this paper
• Design and Synthesis of N‐Substituted Indazole‐3‐Carboxamides as Poly(ADP‐ribose)polymerase‐1 (PARP‐1) Inhibitors †

  2012cites this paper
• Role of poly(ADP‐ribose) polymerases in the regulation of inflammatory processes

  2012cites this paper
• Relationship between NADPH oxidase p22phox C242T, PARP-1 Val762Ala polymorphisms, angiographically verified coronary artery disease and myocardial infarction in South Indian patients with type 2 diabetes mellitus.

  2012cites this paper
• Administration of the PARP Inhibitor Pj34 Ameliorates the Impaired Vascular Function Associated With Enos−/− Mice

  2012cites this paper
• Contribution différentielle du tissu adipeux mâle et femelle dans l’établissement du diabète de type 2 et des altérations cardiovasculaires : rôle de l’apport lipidique

  2012cites this paper
• Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury.

  2011cites this paper
• Human internal thoracic artery grafts exhibit severe morphological and functional damage and spasmic vasomotion due to oxidative stress

  2011cites this paper
• Peroxynitrite-driven mechanisms in diabetes and insulin resistance - the latest advances.

  2011cites this paper
• Postischemic poly (ADP-ribose) polymerase (PARP) inhibition reduces ischemia reperfusion injury in a hind-limb ischemia model.

  2010cites this paper
• Minocycline with aspirin: a therapeutic approach in the treatment of diabetic neuropathy

  2010cites this paper
• Comparative study of the binding characteristics to and inhibitory potencies towards PARP and in vivo antidiabetogenic potencies of taurine, 3-aminobenzamide and nicotinamide

  2010cites this paper
• Glyceraldehyde-3-phosphate dehydrogenase in retinal microvasculature: implications for the development and progression of diabetic retinopathy.

  2010cites this paper
• Poly(ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications.

  2010cites this paper
• Protective effect of nicotinamide against poly(ADP-ribose) polymerase-1-mediated astrocyte death depends on its transporter-mediated uptake.

  2010cites this paper
• Diabetes and antioxidants: myth or reality?

  2010cites this paper
• Increased poly(ADP-ribose) polymerase (PARP)-1 expression and activity are associated with inflammation but not goblet cell metaplasia in murine models of allergen-induced airway inflammation

  2010cites this paper
• Inhibition of ADP ribosylation prevents and cures helicobacter-induced gastric preneoplasia.

  2010influential citation
• PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases.

  2009cites this paper
• Functional and morphologic characterizations of the diabetic mouse corpus cavernosum: comparison of a multiple low-dose and a single high-dose streptozotocin protocols.

  2009cites this paper
• Targeting Oxidant Stress as a Strategy for Preventing Vascular Complications of Diabetes and Metabolic Syndrome

  2009cites this paper
• Diabetic cardiomyopathy--a distinct disease?

  2009cites this paper
• Protective Effects of PARP-1 Knockout on Dyslipidemia-Induced Autonomic and Vascular Dysfunction in ApoE−/− Mice: Effects on eNOS and Oxidative Stress

  2009cites this paper
• Neutrophils recruitment during sepsis: Critical points and crossroads.

  2009cites this paper
• Poly (ADP-ribose) Polymerase Inhibition Improves Endothelial Dysfunction Induced by Hyperhomocysteinemia in Rats

  2009cites this paper
• Biochemical and cellular toxicology of peroxynitrite: implications in cell death and autoimmune phenomenon

  2009cites this paper
• PCB-induced endothelial cell dysfunction: role of poly(ADP-ribose) polymerase.

  2009cites this paper
• Poly(ADP-ribose) polymerase 1 at the crossroad of metabolic stress and inflammation in aging

  2009cites this paper
• Antioxidant therapy in human endocrine disorders.

  2009cites this paper
• Poly (ADP-Ribose) polymerase inhibition attenuates atherosclerotic plaque development in ApoE-/- mice with hyperhomocysteinemia.

  2009cites this paper
• Metformin suppresses high glucose-induced poly(adenosine diphosphate-ribose) polymerase overactivation in aortic endothelial cells.

  2009cites this paper
• Uterine artery function in a mouse model of pregnancy complicated by diabetes.

  2009cites this paper